Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced, progressing hepatocellular carcinoma. N Engl J Med. 2018, 379(1):54-63. doi: 10.1056/NEJMoa1717002.
Advertisement
Articles by Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced, progressing hepatocellular carcinoma. N Engl J Med. 2018, 379(1):54-63. doi: 10.1056/NEJMoa1717002.
Advertisement
Latest Updated Articles
- Study Summary: Cabozantinib for Advanced and Progressing Hepatocellular Carcinoma
Published: November 9th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Exploring Identity, Appearance Experiences Among Patients With Alopecia
5
